• 제목/요약/키워드: CPV-2a

검색결과 49건 처리시간 0.032초

국내에서 유행하는 CPV-2a 분리주에 대한 CPV-2와 CPV-2b 백신의 방어효능 평가 (Evaluation for Protective Effect of CPV-2 and CPV-2b Vaccines against a Korean CPV-2a Isolate in Pups)

  • 정석영;이준석;김현태;김두
    • 한국임상수의학회지
    • /
    • 제31권5호
    • /
    • pp.361-366
    • /
    • 2014
  • 본 연구는 상용화되어 판매되고 있는 CPV-2 백신과 CPV-2b 백신이 국내에서 주로 유행하고 있는 CPV-2a 분리주에 대해 방어능력을 가지는 지를 평가하기 위하여, CPV에 대한 예방접종을 실시하지 않은 생후 9주령의 잡종 강아지 20두를 예방접종 미실시군(대조군) 4두와 예방접종군 16두로 편성하였다. 예방접종 군의 강아지 8두씩은 3주 간격으로 3회에 걸쳐 CPV-2 또는 CPV-2b 백신을 각각 예방접종하였다. 3차 예방접종 2주 후에 모든 강아지에 $1{\times}10^6\;TCID_{50}$의 CPV-2a (VR00174 strain) 바이러스를 경구접종하였으며 강아지들의 임상증상, CPV의 변 내 배출, CPV에 대한 혈청학적 반응에 대하여 2주 동안 관찰하였다. 국내 분리 CPV-2a를 공격접종한 후에, 예방접종을 실시한 모든 강아지에서는 어떠한 임상증상도 나타나지 않았지만 예방접종을 실시하지 않은 강아지들은 식욕부진, 우둔, 구토, 점액 또는 혈액성 설사를 나타내었으며 2두는 공격접종 6일째에 폐사하였다. 예방접종을 실시하지 않은 강아지들에서는 공격접종 4일 후부터 변에서 CPV가 검출되었지만 예방접종을 실시한 강아지에서는 변에서 CPV가 검출되지 않았다. 그리고 예방접종 실시한 강아지들은 1차 예방접종에 의하여 방어수준 이상으로 CPV에 대한 항체를 형성하였다. 본 연구는 현재 국내에서 시판 중인 CPV-2와 CPV-2b 백신이 최근 국내에서 주로 분리되는 CPV-2a에 대하여 교차 방어력을 나타내는 것으로 확인되었다.

Genetic analysis of canine parvovirus vaccine strains in Korea

  • Yang, Dong-Kun;Kim, Byoung-Han;Kim, Yeon-Hee;Lee, Kyung-Woo;Choi, Sung-Suk;Son, Seong-Wan
    • 대한수의학회지
    • /
    • 제49권3호
    • /
    • pp.243-248
    • /
    • 2009
  • After the original identification of canine parvovirus (CPV) type 2 (CPV-2) in 1978, new antigenic variants such as CPV-2a, CPV-2b and CPV-2c have become widespread in the most countries. In this study, the genetic analysis of canine parvovirus was investigated in a total of 13 CPV vaccines, which have been licensed in Korea since late 1980s, and a field isolate of CPV from a dog with CPV infection clinical symptom. The partial VP2 gene of CPV was amplified and sequenced from 13 vaccine strains and one field isolate. The results showed that of the 13 vaccine strains, 10 strains belong to the CPV-2, 2 strains to CPV-2b, the remaining and one isolate to CPV-2a type, respectively. Several mutations of amino acids were detected at residues of the critical region of the commercial vaccine strains. These data suggest that new type of vaccines containing CPV-2a or CPV-2b/2c type may be required for the better prevention of new CPV infection in dog population in Korea, because CPV-2 contained in most licensed vaccines has been replaced by antigenic variants designated CPV-2a or CPV-2b/c in the worldwide dog population.

New genotype classification and molecular characterization of canine and feline parvoviruses

  • Chung, Hee-Chun;Kim, Sung-Jae;Nguyen, Van Giap;Shin, Sook;Kim, Jae Young;Lim, Suk-Kyung;Park, Yong Ho;Park, BongKyun
    • Journal of Veterinary Science
    • /
    • 제21권3호
    • /
    • pp.43.1-43.13
    • /
    • 2020
  • Background: Canine parvovirus (CPV) and feline panleukopenia (FPV) cause severe intestinal disease and leukopenia. Objectives: In Korea, there have been a few studies on Korean FPV and CPV-2 strains. We attempted to investigate several genetic properties of FPV and CPV-2. Methods: Several FPV and CPV sequences from around world were analyzed by Bayesian phylo-geographical analysis. Results: The parvoviruses strains were newly classified into FPV, CPV 2-I, CPV 2-II, and CPV 2-III genotypes. In the strains isolated in this study, Gigucheon, Rara and Jun belong to the FPV, while Rachi strain belong to CPV 2-III. With respect to CPV type 2, the new genotypes are inconsistent with the previous genotype classifications (CPV-2a, -2b, and -2c). The root of CPV-I strains were inferred to be originated from a USA strain, while the CPV-II and III were derived from Italy strains that originated in the USA. Based on VP2 protein analysis, CPV 2-I included CPV-2a-like isolates only, as differentiated by the change in residue S297A/N. Almost CPV-2a isolates were classified into CPV 2-III, and a large portion of CPV-2c isolates was classified into CPV 2-II. Two residue substitutions F267Y and Y324I of the VP2 protein were characterized in the isolates of CPV 2-III only. Conclusions: We provided an updated insight on FPV and CPV-2 genotypes by molecular-based and our findings demonstrate the genetic characterization according to the new genotypes.

Isolation and identification of canine parvovirus type 2b in Korean dogs

  • Yang, Dong-Kun;Kang, Kyung-Suk;Jo, Hyun-Ye;Kim, Ha-Hyun;Choi, Sung-Suk;Song, Jae-Young
    • 대한수의학회지
    • /
    • 제55권3호
    • /
    • pp.163-167
    • /
    • 2015
  • Canine parvovirus (CPV) is a major diarrhea-causing agent in puppies. Since CPV type 2 (CPV-2) emerged in 1978, new antigenic variants including CPV-2a, CPV-2b, and CPV-2c have been identified in many countries. Two puppies died suddenly at a veterinary clinic in Gyeonggi province, South Korea. Two viruses were isolated in A72 cells, confirmed as CPV strains based on a CPV rapid kit and an indirect fluorescence test and designated QIACP1403 and QIACP1404. The nucleotide sequences of complete VP2 genes of QIACP1403 and QIACP1404 were determined, and the corresponding amino acid sequences were deduced. Molecular analyses revealed that the QIACP1403 and QIACP1404 isolates were type CPV-2b. Several mutated amino acids were detected on VP2 gene residues of the two isolates. Phylogenetic analyses showed that the two isolates were most closely related to strain CPV-BM11, which was isolated from Chinese dogs in 2011. Our results suggest that these isolates may be a candidate for a vaccine to prevent CPV infection in dogs after conducting passages of the isolates in an in vitro culture system.

Evaluation of commercial immunochromatography test kits for diagnosing canine parvovirus

  • Lee-Sang Hyeon;Dong-Kun Yang;Eun-Ju Kim;Yu-Ri Park;Hye Jeong Lee;Bang-Hun Hyun
    • 대한수의학회지
    • /
    • 제63권2호
    • /
    • pp.19.1-19.6
    • /
    • 2023
  • Rapid immunochromatography test (RICT) kits are commonly used for the diagnosis of canine parvovirus (CPV) because of their rapid turnaround time, simplicity, and ease of use. However, the potential for cross-reactivity and low sensitivity can yield false-positive or false-negative results. There are 4 genotypes of CPV. Therefore, evaluating the performance and reliability of RICT kits for CPV detection is essential to ensure accurate diagnosis for appropriate treatment. In this study, we evaluated the performance of commercial RICT kits in the diagnosis of all CPV genotypes. The cross-reactivity of 6 commercial RICT kits was evaluated using 8 dog-related viruses and 4 bacterial strains. The limit of detection (LOD) was measured for the 4 genotypes of CPV and feline panleukopenia virus. The tested kits showed no cross-reactivity with the 8 dog-related viruses or 4 bacteria. Most RICT kits showed strong positive results for CPV-2 variants (CPV-2a, CPV-2b, and CPV-2c). However, the 2 kits produced negative results for CPV-2 or CPV-2b at a titer of 105 FAID50/mL, which may result in inaccurate diagnoses. Therefore, some kits need to improve their LOD by increasing their binding efficiency to detect all CPV genotypes.

국내에서 분리된 canine parvovirus의 구조유전자 cloning과 염기서열 분석 (Cloning and sequencing of the gene encoding structural protein of canine parvovirus isolated in Korea)

  • 박종현;송재영;이중복;현방훈;안수환;전무형
    • 대한수의학회지
    • /
    • 제32권4호
    • /
    • pp.555-567
    • /
    • 1992
  • In this study gene encoding structural proteins of a CPV isolate was cloned and sequenced to elucidate the molecular genetical properties of the canine parvoviruses isolated from the field. Six recombinant plasmids of pEP3, p1471, p2070, pEP069, pEP338 and p14711p were constructed from the map positions 22 to 98 of RF DNA to clone the VP1 and VP2 genes of CPV-V20. Sequentialy the gene comprising 3780 nucleotides were sequenced by dideoxy chain termination method. When nucleotide sequence of gene encoding the structural proteins of CPV-V20 was compared with those of other strains, CPV-N, CPV-d and CPV-780929 published previously, DNA, homologies to CPV-V20 were 99.87% with CPV-N, 99.73% with CPV-d, 96.85% with CPV-780929 and 98.4% with FPLV-Carl, respectively. The DNA sequence data of CPV-V20 showed seven point mutations and also deletion of 135 nucleotides from the nucleotide position 4745 to 4879 located in the 3'-noncoding region of CPV-N.

  • PDF

Incidence of canine viral diseases and prevalence of virus neutralization antibodies of canine distemper virus, adenovirus type 2, parvovirus, and parainfluenza virus type 5 in Korean dogs

  • Dong-Kun Yang;Ha-Hyun Kim;Hye Jeong Lee;Young-Ju Cheong;Lee-Sang Hyeon;Minuk Kim;Bang-Hun Hyun
    • 대한수의학회지
    • /
    • 제64권1호
    • /
    • pp.3.1-3.8
    • /
    • 2024
  • Canine distemper virus (CDV), canine adenovirus type 2 (CAV-2), canine parvovirus (CPV), and canine parainfluenza virus 5 (CPIV-5) are the major viral pathogens in dogs. Despite the availability of vaccines for dogs against these 4 viral pathogens, investigations of antibodies against these pathogens have rarely been reported in South Korea. In this study, we investigated the recent incidence of viral diseases in dogs and conducted sero-surveillance for CDV, CAV-2, CPV, and CPIV-5 in Korean dogs. The most frequently diagnosed canine viral disease in Korean dog samples from 2000 to 2022 was CPV infection, which accounted for 48.7% (464/953) of the cases. A total of 400 dog serum samples collected between 2019 and 2022 were screened for the presence of virus-neutralizing antibodies against CDV, CAV-2, CPV, and CPIV-5. The overall seropositivity rates for CDV, CAV-2, CPV, and CPIV-5 were 83.8%, 77.8%, 99.3%, and 82.0%, respectively. The protection rate against CPV was the highest (98.3%) and that against CAV-2 was the lowest (44.8%) in dog sera. Male and female dogs showed no significant differences in seropositivity rates. CDV and CPIV-5 seropositivity increased with age in dogs, and the highest incidence and seropositivity rates of CPV indicated that Korean dogs have been continuously exposed to wild CPV, and that CPV is a pathogen that urgently requires attention among canine viral diseases.

Evaluation for Serological Patterns and Fecal Viral Shedding by Hemagglutination Inhibition Test and Real-time PCR in Korean CPV-2 isolates

  • Moon, Hyeong-Sun;Lee, Joon-Seok;Nam, So-Jeong;Yoon, Soon-Seek;Kang, Moon-Il;Jeoung, Seok-Yong;Kim, Doo;Hyun, Chang-Baig
    • 한국임상수의학회지
    • /
    • 제25권6호
    • /
    • pp.435-439
    • /
    • 2008
  • We evaluated the patterns of serology and fecal viral shedding for any differences by hemagglutination inhibition (HI) and real-time PCR on Korean CPV-2 isolates (CPV-2a-I, CPV-2a-V and CPV-2b). We successfully detected fecal viral shedding from samples extracted 2-3 d.p.i., regardless of the onset of clinical signs. In addition, the pattern of viral shedding differed depending on the CPV-2 isolates used for inoculation. We also observed differences in the serological pattern that was also depended on the CPV-2 isolates inoculated. The onset and amount of fecal viral shedding were not correlated with the level of antibody titers in this study. Our study is a valuable resource for understanding the different pathobiology of the CPV-2 isolates and the correlation between the patterns of serum antibody titer and fecal viral shedding.

Characterization of Natural Compounds as Inhibitors of NS1 Endonuclease from Canine Parvovirus Type 2

  • So-Hyung Kwak;Hayeong Kim;Hyeli Yun;Juho Lim;Dong-Hyun Kang;Doman Kim
    • Journal of Microbiology and Biotechnology
    • /
    • 제33권6호
    • /
    • pp.788-796
    • /
    • 2023
  • Canine parvovirus type 2 (CPV-2) has high morbidity and mortality rates in canines. Nonstructural protein 1 (NS1) of CPV-2 has endonuclease activity, initiates viral DNA replication, and is highly conserved. Thus, it is a promising target for antiviral inhibitor development. We overexpressed a 41.9 kDa active recombinant endonuclease in Escherichia coli and designed a nicking assay using carboxyfluorescein and quencher-linked ssDNA as substrates. The optimal temperature and pH of the endonuclease were 37℃ and pH 7, respectively. Curcumin, bisdemethoxycurcumin, demethoxycurcumin, linoleic acid, tannic acid, and α-tocopherol inhibited CPV-2 NS1 endonuclease with IC50 values of 0.29 to 8.03 µM. The extracted turmeric, yerba mate, and sesame cake suppressed CPV-2 NS1 endonuclease with IC50 values of 1.48, 7.09, and 52.67 ㎍/ml, respectively. The binding affinity between curcumin, the strongest inhibitor, and CPV-2 NS1 endonuclease by molecular docking was -6.4 kcal/mol. Curcumin inhibited CPV-2 NS1 endonuclease via numerous hydrophobic interactions and two hydrogen bonds with Lys97 and Pro111 in the allosteric site. These results suggest that adding curcuminoids, linoleic acid, tannic acid, α-tocopherol, extracted turmeric, sesame cake, and yerba to the diet could prevent CPV-2 infection.

SOG렌즈를 적용한 집광형 태양전지모듈 특성 (A Characteristics of the Applied SOG Lens for the CPV Module)

  • 정병호;이강연;박주훈;문은아;이상현;김대곤
    • 전기학회논문지P
    • /
    • 제61권2호
    • /
    • pp.97-102
    • /
    • 2012
  • CPV system in the desert areas or areas near the equator, as is suitable for high-temperature region. As compared to silicon solar cells, CPV system have a high proportion of a BOS (balance of system). Solar cells because of its low proportion when designing a module technology is applied in a variety of ways. Applied to the CPV system is classified into two kinds of optical technology. One of those using fresnel lens uses refraction of light energy. The other is a mirror reflection of the structure using sprays. Both of these two ways to condense the sun to collect solar cell is a form of light. And goals by using a small solar cell materials is to produce more energy. In this paper, suitable for a domestic environment, with the aim CPV Manufacturing Technology, built on a variety of modular process technology to the development of a prototype performance analysis was carried out. In particular, silicone coated on the glass by the method of implementation of the Fresnel lens SOG(Silicon on glass) by applying the lens to absorb the solar spectrum was broad. In addition to, for the analyze to characteristics of the CPV module, developed CPV module performance and generating characteristics studied. These related technology through research and development of high-performance multi-junction solar cells, modules, development of concentrating solar power systems to facilitate the growth of the market is considered to be.